|
Post by boca1girl on May 16, 2017 10:47:04 GMT -5
Cowgirl: You often describe the management as "arrogant" in regards to "going it alone" in marketing Afrezza. How are you so sure that they didn't have a choice in the matter? I think the worst thing for current shareholders is to sell out now when the SP is in the toilet.
My biggest complaint with management is the silence and secrecy. I was expecting more transparency that management promised us after SNY backed out. I just can't understand why management and the BOD aren't more vocal to support the company and the SP.
|
|
|
Post by slugworth008 on May 16, 2017 11:12:53 GMT -5
You would think if there is some good news it would be announced at the ASM. Boy we could sure use good news & not the usual forward looking comments, hopes etc..... Time for Afrezza to take off! Something is going on and will come out at the ASM. I hope your right KC - My fingers are crossed and I'm facing east and chanting for this one.
|
|
|
Post by dreamboatcruise on May 16, 2017 11:48:55 GMT -5
iPhone, One Drop, Middle East country, Daman, Amgen, 10.5 ton shipment quote request to Abu Dhabi (if legit), Apple hires 200 PHDs to focus on real-time glucose monitoring...this is one fascinating puzzle and no one even knows if we're even playing with the right pieces. GLTA Lots of dots is often the measles rather than a puzzle. But I'm really excited now that the full resources of Apple are behind Mannkind. Now that iPhone users can also use Afrezza it will be off to the races.
|
|
|
Post by dreamboatcruise on May 16, 2017 11:52:36 GMT -5
Cowgirl: You often describe the management as "arrogant" in regards to "going it alone" in marketing Afrezza. How are you so sure that they didn't have a choice in the matter? I think the worst thing for current shareholders is to sell out now when the SP is in the toilet. My biggest complaint with management is the silence and secrecy. I was expecting more transparency that management promised us after SNY backed out. I just can't understand why management and the BOD aren't more vocal to support the company and the SP. I think you are probably right in not having a choice, though I'd pose a similar question to you about what you can't understand. How are you so sure there is anything else that isn't a lie that they could say that would be "supportive"? Maybe they have given us all the good news that actually exists.
|
|
|
Post by myocat on May 16, 2017 11:56:08 GMT -5
iPhone, One Drop, Middle East country, Daman, Amgen, 10.5 ton shipment quote request to Abu Dhabi (if legit), Apple hires 200 PHDs to focus on real-time glucose monitoring...this is one fascinating puzzle and no one even knows if we're even playing with the right pieces. GLTA Lots of dots is often the measles rather than a puzzle. But I'm really excited now that the full resources of Apple are behind Mannkind. Now that iPhone users can also use Afrezza it will be off to the races. "Now that iPhone users can also use Afrezza it will be off to the races." I am an Iphone user but I am not using Afrezza....Funny statement
|
|
|
Post by dreamboatcruise on May 16, 2017 12:01:58 GMT -5
Lots of dots is often the measles rather than a puzzle. But I'm really excited now that the full resources of Apple are behind Mannkind. Now that iPhone users can also use Afrezza it will be off to the races. "Now that iPhone users can also use Afrezza it will be off to the races." I am an Iphone user but I am not using Afrezza....Funny statement Your NOT? I'm sure it won't be long now that "iPhone" and "200 Apple PhD's" are linked to Mannkind. Glad you found my humor amusing.
|
|
|
Post by boca1girl on May 16, 2017 12:21:50 GMT -5
Dreamboat: Yes, maybe they have disclosed all of the good news that they can legally disclose, but how about a 2-3 year strategy? Share with us their plans (with dates) on getting approvals in other countries. Sales projections for US sales. Clear product roadmap for approvals for the next 3 Technosphere drugs with associated development costs. I've never been associated with a "PUBLIC" company that has been so reluctant to share information with shareholders.
|
|
|
Post by bradleysbest on May 16, 2017 12:26:59 GMT -5
Please no more projections! Most of their forward moving projection shave not panned out. I expect an announcement of an agreement with a Middle Eastern country. It would be a start since sales have not taken off here in the US.
|
|
|
Post by kc on May 16, 2017 12:29:57 GMT -5
If there is a major announcement, it would have to appear 1st as a PR, say on the morning of the meeting. That happened to me 6 years ago, going to the Green Mountain Coffee (GMCR) ASM meeting. At 6:30 AM, a PR announcing a deal with Starbucks. I could see inhaling Afrezza with a Starbucks...so sweet... have to get Micky D's coffee only a buck. Can't afford Five bucks coffee until MannKind gets a good return.
|
|
|
Post by cjm18 on May 16, 2017 12:33:03 GMT -5
Lots of dots but do any lead to $ to expand the runway until we get peds approval? That is the question.
|
|
|
Post by dreamboatcruise on May 16, 2017 12:44:06 GMT -5
Dreamboat: Yes, maybe they have disclosed all of the good news that they can legally disclose, but how about a 2-3 year strategy? Share with us their plans (with dates) on getting approvals in other countries. Sales projections for US sales. Clear product roadmap for approvals for the next 3 Technosphere drugs with associated development costs. I've never been associated with a "PUBLIC" company that has been so reluctant to share information with shareholders. A company without money can only have a wish list of things they want to do, which I really wouldn't call a plan or a strategy. Management has actually communicated some things... it's just that the reality isn't what you were hoping. They've shown the pipeline, but basically are saying they lack funds to pursue clinical trials. You want them to develop an artificial timeline of what they would do if they had money, and then update us every month that due to lack of funds they've been stalled and the entire timeline has shifted right by another month... and another month... and... ? I actually do agree with you that management could be more forthcoming... but much of it boils down to lack of money. Should they give aspirational plan with caveat that they have no idea how to pay for it, or realistic plan? The latter may be more an ongoing reactive process as the former continues to not materialize. I too am frustrated.
|
|
|
Post by cyn on May 16, 2017 13:23:08 GMT -5
Question… Does anyone know for certain whether Dr. Khaled Al Jaberi, Director of Health Regulation Division for the Health Authority, Abu Dhabi (HADD) is one in the same to Dr. Khaled Al Jaberi, Chief of Endocrinology, Mafraq Hospital, Abu Dhabi back in 2010? Just trying to connect some of the dots where possible. www.haad.ae/haad/tabid/730/Default.aspxwww.haad.ae/haad/tabid/1337/Default.aspxwww.abudhabicme.com/main/directors.phpEven though a bit outdated (2010), the following articles quote Dr. Khaled Al Jaberi, Chief of Endocrinology, Mafraq Hospital, Abu Dhabi regarding the growing obesity and diabetes in the UAE. If Endocrinologist, Dr. Khaled Al Jaberij is indeed one in the same to Dr. Khaled Al Jaberi, Director of Health Regulation Division for HADD … I see this as nothing but highly favorable to getting Affrezza approved in the UAE. JMHO www.thenational.ae/news/uae-news/health/diabetes-affecting-one-in-four-emiratis-health-screenings-show gulfnews.com/news/uae/health/75-per-cent-of-uae-population-is-overweight-1.596687 www.khaleejtimes.com/article/20100315/ARTICLE/303159876/1002
|
|
|
Post by dreamboatcruise on May 16, 2017 13:55:36 GMT -5
Question… Does anyone know for certain whether Dr. Khaled Al Jaberi, Director of Health Regulation Division for the Health Authority, Abu Dhabi (HADD) is one in the same to Dr. Khaled Al Jaberi, Chief of Endocrinology, Mafraq Hospital, Abu Dhabi back in 2010? Just trying to connect some of the dots where possible. www.haad.ae/haad/tabid/730/Default.aspxwww.haad.ae/haad/tabid/1337/Default.aspxwww.abudhabicme.com/main/directors.phpEven though a bit outdated (2010), the following articles quote Dr. Khaled Al Jaberi, Chief of Endocrinology, Mafraq Hospital, Abu Dhabi regarding the growing obesity and diabetes in the UAE. If Endocrinologist, Dr. Khaled Al Jaberij is indeed one in the same to Dr. Khaled Al Jaberi, Director of Health Regulation Division for HADD … I see this as nothing but highly favorable to getting Affrezza approved in the UAE. JMHO www.thenational.ae/news/uae-news/health/diabetes-affecting-one-in-four-emiratis-health-screenings-show gulfnews.com/news/uae/health/75-per-cent-of-uae-population-is-overweight-1.596687 www.khaleejtimes.com/article/20100315/ARTICLE/303159876/1002Yes, because we know how almost all endos have been super positive about getting Afrezza into patients' hands
|
|
|
Post by cjm18 on May 16, 2017 14:50:43 GMT -5
Rmemebr. The shortest distance between 2 dots is a straight line.
|
|
|
Post by cyn on May 16, 2017 14:56:25 GMT -5
Dreamboat, Yes indeed, draconian US Endos just seem to sit on their laurels, pumping to patients what’s easy and convenient to titrate while controlled by the private insurance companies. Let’s hope that the Abu Dhabi Endos working for UAE public regulatory authorities like HADD and SEHA (among others), are proactive and committed to aggressively employing all available treatment options for their diabetic patients. After reviewing the following publication, the UAE healthcare sector appears to be so, embracing new technologies and innovative, holistic approaches to healthcare… and is far from suffering from risk aversion and stagnation like many of our US Endos. usuaebusiness.org/wp-content/uploads/2014/06/HealthcareReport_Update_June2014.pdf
|
|